H. Kulasekara

发表

Precursor acquisition independent from ion count: how to dive deeper into the proteomics ocean.

Samuel I. Miller, D. Goodlett, S. Shaffer, 2009, Analytical chemistry.

Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes.

Samuel I. Miller, L. Hoffman, R. Gibson, 2014, American journal of respiratory and critical care medicine.

Asymmetrical Distribution of the Second Messenger c-di-GMP upon Bacterial Cell Division

Matthias Christen, Bridget R. Kulasekara, Samuel I. Miller, 2010, Science.

Conditional toxicity and synergy drive diversity among antibacterial effectors

H. Kulasekara, S. B. Peterson, M. Radey, 2018, Nature Microbiology.

c-di-GMP heterogeneity is generated by the chemotaxis machinery to regulate flagellar motility

Paul A. Wiggins, Samuel I. Miller, H. Kulasekara, 2013, eLife.

Threonine phosphorylation times bacterial secretion

Samuel I. Miller, H. Kulasekara, 2007, Nature Cell Biology.

Subinhibitory Concentration of Kanamycin Induces the Pseudomonas aeruginosa type VI Secretion System

A. Filloux, H. Kulasekara, Cerith Jones, 2013, PloS one.

The response threshold of Salmonella PilZ domain proteins is determined by their binding affinities for c‐di‐GMP

Samuel I. Miller, I. S. Pultz, H. Kulasekara, 2012, Molecular microbiology.

Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression.

Samuel I. Miller, L. Hoffman, J. Emerson, 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

The bacterial second messenger c‐di‐GMP: mechanisms of signalling

Samuel I. Miller, I. S. Pultz, H. Kulasekara, 2011, Cellular microbiology.

Identification of Small‐Molecule Modulators of Diguanylate Cyclase by FRET‐Based High‐Throughput Screening

Samuel I. Miller, H. Kulasekara, B. Kulasekara, 2018, Chembiochem : a European journal of chemical biology.

Identification of Small Molecule Modulators of Diguanylate Cyclase by FRET-based High-Throughput-Screening

Samuel I. Miller, H. Kulasekara, B. Kulasekara, 2018, bioRxiv.

The molecular basis for the specificity of fimE in the phase variation of type 1 fimbriae of Escherichia coli K‐12

I. Blomfield, H. Kulasekara, 1999, Molecular microbiology.

Prevalence of SARS-CoV-2 Contamination on Food Plant Surfaces as Determined by Environmental Monitoring

H. Kulasekara, M. Samadpour, K. Deng, 2021, Journal of Food Protection.

Coordinately regulated interbacterial antagonism defense pathways constitute a bacterial innate immune system

S. Salipante, H. Kulasekara, S. B. Peterson, 2021, bioRxiv.

Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients

David A. D'Argenio, Samuel I. Miller, L. Hoffman, 2007, Molecular microbiology.

β-Barrel outer membrane proteins suppress mTORC2 activation and induce autophagic responses

Samuel I. Miller, Guoxing Wang, H. Kulasekara, 2018, Science Signaling.

The Acinetobacter baumannii Mla system and glycerophospholipid transport to the outer membrane

Samuel I. Miller, J. Kollman, H. Kulasekara, 2018, bioRxiv.

A novel two‐component system controls the expression of Pseudomonas aeruginosa fimbrial cup genes

S. Lory, A. Filloux, H. Kulasekara, 2004, Molecular microbiology.

Nutrient Availability as a Mechanism for Selection of Antibiotic Tolerant Pseudomonas aeruginosa within the CF Airway

Samuel I. Miller, L. Hoffman, D. Stahl, 2010, PLoS pathogens.

Pyomelanin-producing Pseudomonas aeruginosa selected during chronic infections have a large chromosomal deletion which confers resistance to pyocins.

Samuel I. Miller, L. Hoffman, H. Kulasekara, 2016, Environmental microbiology.

In vivo protein interaction network analysis reveals porin-localized antibiotic inactivation in Acinetobacter baumannii strain AB5075

Devin K Schweppe, Chunxiang Zheng, Chad R Weisbrod, 2016, Nature Communications.

A broadly distributed toxin family mediates contact-dependent antagonism between gram-positive bacteria

M. Surette, E. Borenstein, Y. Goo, 2017, eLife.

Pseudomonas aeruginosa phenotypes associated with eradication failure in children with cystic fibrosis.

Samuel I. Miller, L. Hoffman, R. Gibson, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Environmental monitoring shows SARS-CoV-2 contamination of surfaces in food plants

H. Kulasekara, M. Samadpour, K. Deng, 2020, medRxiv.

Orientational control of fimE expression in Escherichia coli

I. Blomfield, H. Kulasekara, A. Bonnen, 2001, Molecular microbiology.

Evidence for Induction of Integron-Based Antibiotic Resistance by the SOS Response in a Clinical Setting

Samuel I. Miller, H. Kulasekara, D. Mazel, 2012, PLoS pathogens.

Genome-specific gas-phase fractionation strategy for improved shotgun proteomic profiling of proteotypic peptides.

Samuel I. Miller, D. Goodlett, S. Shaffer, 2008, Analytical chemistry.

Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants

E. Sokurenko, H. Kulasekara, M. Samadpour, 2021, Journal of clinical microbiology.

Acquisition and Evolution of the exoU Locus in Pseudomonas aeruginosa

S. Lory, M. Wolfgang, H. Kulasekara, 2006, Journal of bacteriology.

Cryo-EM structure of the A. baumannii MLA complex at 8.7 A resolution

Samuel I. Miller, J. Kollman, H. Kulasekara, 2019 .

Precursor acquisition independent from ion count: how to dive deeper into the proteomics ocean.

Samuel I. Miller, D. Goodlett, S. Shaffer, 2009, Analytical chemistry.

The bacterial second messenger c‐di‐GMP: mechanisms of signalling

Samuel I. Miller, I. S. Pultz, H. Kulasekara, 2011, Cellular microbiology.